BondTrue LLC, founded with the mission to revolutionize surgical procedures, focuses on developing automated incision and closure technology. The company aims to enhance surgical precision and efficiency through its patented device (#9,408,672). Their core product is designed to automate the process of surgical incisions and closures, targeting the medical device market with a particular emphasis on improving outcomes in surgical settings.
Notable affiliations include funding from the National Science Foundation and Maryland Industrial Partnerships (MIPS) of the Maryland Technology Enterprise Institute. BondTrue has received a Phase II MIPS award worth $100,000 and is a TEDCO Portfolio Company. Key achievements include winning the ExportMD grant and being featured in The Baltimore Business Journal. BondTrue's innovations have made significant impacts in the medical device industry, particularly in enhancing surgical automation and precision.
